| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.031 | 0.6 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.031 | 0.6 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |